Cargando…
Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
The field of biomarker research has almost reached unmanageable proportions in chronic obstructive pulmonary disease (COPD). The developments of new technology platforms have generated a huge information data base, both cross sectionally and increasingly, longitudinally. The knowledge emerging provi...
Autor principal: | Stockley, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923613/ https://www.ncbi.nlm.nih.gov/pubmed/24532968 http://dx.doi.org/10.2147/COPD.S42362 |
Ejemplares similares
-
The genetics of chronic obstructive pulmonary disease
por: Wood, Alice M, et al.
Publicado: (2006) -
Chronic obstructive pulmonary disease: towards pharmacogenetics
por: Wood, Alice M, et al.
Publicado: (2009) -
Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
por: Crisford, Helena, et al.
Publicado: (2018) -
An overview of exacerbations of chronic obstructive pulmonary disease: Can tests of small airways' function guide diagnosis and management?
por: Alobaidi, Nowaf Y., et al.
Publicado: (2020) -
Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Stockley, Robert A., et al.
Publicado: (2019)